LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | A443654 | 0.12 | uM | LJP6 | 72 | hr | 658 | 940 | 3846 | 0.2446 | 0.0886 |
Hs 578T | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3218 | 3846 | 0.8368 | 0.8031 |
Hs 578T | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 658 | 3392 | 3846 | 0.8819 | 0.8576 |
Hs 578T | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 658 | 2417 | 3846 | 0.6284 | 0.5517 |
Hs 578T | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 658 | 2719 | 3846 | 0.7070 | 0.6466 |
Hs 578T | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 658 | 2457 | 3846 | 0.6388 | 0.5643 |
Hs 578T | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 658 | 770 | 3846 | 0.2004 | 0.0353 |
Hs 578T | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3625 | 3846 | 0.9427 | 0.9309 |
Hs 578T | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3174 | 3846 | 0.8253 | 0.7892 |
Hs 578T | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3235 | 3846 | 0.8412 | 0.8084 |
Hs 578T | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 3894 | 3846 | 1.0125 | 1.0151 |
Hs 578T | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 658 | 4026 | 3846 | 1.0468 | 1.0564 |
Hs 578T | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 658 | 683 | 3846 | 0.1777 | 0.0079 |
Hs 578T | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 658 | 468 | 3846 | 0.1218 | -0.0596 |
Hs 578T | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3574 | 3846 | 0.9293 | 0.9148 |
Hs 578T | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 658 | 3609 | 3846 | 0.9384 | 0.9256 |
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 658 | 4061 | 3846 | 1.0560 | 1.0676 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3527 | 3846 | 0.9171 | 0.9000 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3227 | 3846 | 0.8390 | 0.8058 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 1468 | 3846 | 0.3817 | 0.2540 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 658 | 708 | 3846 | 0.1843 | 0.0158 |
Hs 578T | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 2222 | 3846 | 0.5779 | 0.4908 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 658 | 3975 | 3846 | 1.0337 | 1.0406 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3750 | 3846 | 0.9752 | 0.9701 |
Hs 578T | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3153 | 3846 | 0.8199 | 0.7827 |